Location and function of VPAC1, VPAC2 and NPR-C receptors in VIP-induced vasodilation of porcine basilar arteries

被引:33
|
作者
Grant, S
Lutz, EM
McPhaden, AR
Wadsworth, RM
机构
[1] Univ Strathclyde, Dept Physiol & Pharmacol, Glasgow G4 0NR, Lanark, Scotland
[2] Univ Strathclyde, Dept Biosci, Glasgow G4 0NR, Lanark, Scotland
[3] Glasgow Royal Infirm, Dept Pathol, Glasgow G4 0SF, Lanark, Scotland
来源
关键词
NPR-C receptor; vasoactive intestinal peptide; VPAC receptors;
D O I
10.1038/sj.jcbfm.9600163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vasoactive intestinal peptide (VIP) is a vasodilator peptide present in cerebrovascular nerves. Vasoactive intestinal peptide can activate VPAC(1), VPAC(2) and the NPR-C receptor. This study sought to determine the receptors involved in VIP-induced vasodilation of porcine basilar arteries. Porcine basilar arteries contained the messenger ribonucleic acid of all three receptors. Immunocytochemical analysis of porcine basilar arteries revealed that the VPAC(1) receptor is expressed on the endothelium, VPAC(2) on the outer layers of the media and the NPR-C receptor throughout the artery, including nerves. Vasodilator responses to all receptor agonists showed that the receptors are functional. The vasodilator response to the VPAC(1) receptor agonist was inhibited by L-NAME and abolished by endothelial denudation. Vasodilation induced by Ro-25-1553, the VPAC(2) agonist, was unaffected by NOS inhibition or removal of the endothelium. Activation of the NPR-C receptor produced a vasodilation, which was susceptible to NOS inhibition and independent of endothelium. The vasodilator response to electrical stimulation at 20 Hz was attenuated by PG-99-465, the VPAC(2) antagonist. This study shows that all known VIP receptors are involved in VIP-mediated vasodilation of porcine basilar arteries. The VPAC(1) receptor is located on the endothelium and elicits vasodilation by generating nitric oxide (NO). The VPAC(2) receptor is mainly expressed in the outer layers of the smooth muscle and induces vasodilation independently of NO in response to VIP released from intramural nerves. The NPR-C receptor produces NO-dependent vasodilation independently of the endothelium by stimulation of nNOS in intramural nerves.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 33 条
  • [21] Differences in the Expression of VPAC2 Receptors and Adenylyl Cyclase V/VI and VIP-Induced cAMP Generation in Phasic and Tonic Smooth Muscles
    Al-Shboul, Othman
    Mahavadi, Sunila
    Rajagopal, Senthilkumar
    Zhou, Ruizhe
    Murthy, Karnam S.
    FASEB JOURNAL, 2011, 25
  • [22] Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies
    Schulz, S
    Röcken, C
    Mawrin, C
    Weise, W
    Hölllt, V
    Schulz, S
    CLINICAL CANCER RESEARCH, 2004, 10 (24) : 8235 - 8242
  • [23] Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist -: Alanine scanning and molecular modeling of the peptide
    Nicole, P
    Lins, L
    Rouyer-Fessard, C
    Drouot, C
    Fulcrand, P
    Thomas, A
    Couvineau, A
    Martinez, J
    Brasseur, R
    Laburthe, M
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (31) : 24003 - 24012
  • [24] VPAC1 and VPAC2 receptors mediate tactile hindpaw hypersensitivity and carotid artery dilatation induced by PACAP38 in a migraine relevant mouse model
    Guo, Song
    Rasmussen, Rikke Holm
    Hay-Schmidt, Anders
    Ashina, Messoud
    Asuni, Ayodeji A.
    Jensen, Jeppe Moller
    Holm, Anja
    Lauritzen, Sabrina Prehn
    Dorsam, Glenn
    Hannibal, Jens
    Georg, Birgitte
    Kristensen, David Mobjerg
    Olesen, Jes
    Christensen, Sarah Louise
    JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01):
  • [25] Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain
    Joo, KM
    Chung, YH
    Kim, MK
    Nam, RH
    Lee, BL
    Lee, KH
    Cha, CI
    JOURNAL OF COMPARATIVE NEUROLOGY, 2004, 476 (04) : 388 - 413
  • [26] Domains determining agonist selectivity in chimaeric VIP2 (VPAC2)/PACAP (PAC1) receptors
    Lutz, EM
    MacKenzie, CJ
    Johnson, M
    West, K
    Morrow, JA
    Harmar, AJ
    Mitchell, R
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 128 (04) : 934 - 940
  • [27] A cloned frog vasoactive intestinal polypeptide pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals
    Alexandre, D
    Anouar, Y
    Jegou, S
    Fournier, A
    Vaudry, H
    ENDOCRINOLOGY, 1999, 140 (03) : 1285 - 1293
  • [28] EFFECT OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE AND ITS ANALOGUES ON THE SPECIFIC PAC1 AND VPAC1/VPAC2 RECEPTORS ON THE CELL BODIES OF PRIMARY SENSORY NEURONS AND TRANSFECTED CELL LINES
    Szoke, E.
    Saghy, E.
    Payrits, M.
    Reglodi, D.
    Toth, G.
    Couvineau, A.
    Helyes, Z.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2014, 115 : 114 - 114
  • [29] PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE AND ITS ANALOGUES ACTIVATE THE SPECIFIC PAC1 AND VPAC1/VPAC2 RECEPTORS ON THE CELL BODIES OF PRIMARY SENSORY NEURONS AND TRANSFECTED CELL LINES
    Saghy, E.
    Szoke, E.
    Banki, E.
    Reglodi, D.
    Toth, G.
    Couvineau, A.
    Helyes, Zs
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 51 : S204 - S205
  • [30] Receptor activity modifying proteins (RAMPs) interact with the VPAC2 receptor and CRF1 receptors and modulate their function
    Wootten, D.
    Lindmark, H.
    Kadmiel, M.
    Willcockson, H.
    Caron, K. M.
    Barwell, J.
    Drmota, T.
    Poyner, D. R.
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 168 (04) : 822 - 834